NCT04342169View on ClinicalTrials.gov

University of Utah COVID-19 Hydrochloroquine Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

April 4, 2020

Primary Completion Date

October 30, 2021

Study Completion Date

November 15, 2021

Conditions
Coronavirus InfectionCoronavirusInfectious Disease
Interventions
DRUG

Hydroxychloroquine

HCQ 400mg po BID x 1 day, then 200mg po BID x 4 days

DRUG

Placebo oral tablet

Placebo to be taken on the same schedule as HCQ.

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04342169 - University of Utah COVID-19 Hydrochloroquine Trial | Biotech Hunter | Biotech Hunter